首站-论文投稿智能助手
典型文献
A SNIPpet of safety:a Goldilocks approach in CAR-T therapy
文献摘要:
Despite the remarkable efficacy of chimeric antigen receptor(CAR)T-cells in B-cell malignancies,their full potential in solid tumors has not yet been achieved.In a recent publication in Cell,Labanieh et al.developed a druggable CAR T-cell construct that allows optimal fine-tuning of CAR T-cells to achieve maximal efficacy and reduce toxicity. With the advent of CD19 targeting using chimeric antigen receptor(CAR)T-cells,the potential of immunotherapy,in particular adoptive cell therapy,became a reality.CD19-directed CAR T-cells have been transformative-eradicating disease in the most chemotherapy-refractory patients,with potential to induce long-term durable remissions.While inflammatory toxicities related to T-cell expansion can be life-threatening,the iterative recognition of and approach to treatment of cytokine release syndrome(CRS)and sequelae thereof,along with the development of pre-emptive interventions and supportive care measures,1 facilitated the safe implementation across patient populations.Additionally,the tolerance for on-target,off-tumor targeting enabled implementation of a therapeutic approach where broad antigen targeting was not of substantial concern.
文献关键词:
作者姓名:
Mehdi Benzaoui;Naomi Taylor;Nirali N.Shah
作者机构:
Pediatric Oncology Branch,Center for Cancer Research,National Cancer Institute,National Institutes of Health,Bethesda,MD,USA;Institut de Génétique Moléculaire de Montpellier,Univ Montpellier,CNRS,Montpellier,France
引用格式:
[1]Mehdi Benzaoui;Naomi Taylor;Nirali N.Shah-.A SNIPpet of safety:a Goldilocks approach in CAR-T therapy)[J].细胞研究(英文版),2022(07):603-604
A类:
SNIPpet,Labanieh,remissions
B类:
safety,Goldilocks,approach,CAR,Despite,remarkable,efficacy,chimeric,antigen,receptor,cells,malignancies,their,full,potential,solid,tumors,has,yet,been,achieved,In,recent,publication,Cell,developed,druggable,construct,that,allows,optimal,fine,tuning,maximal,reduce,toxicity, With,advent,CD19,targeting,using,immunotherapy,particular,adoptive,became,reality,directed,have,transformative,eradicating,disease,most,chemotherapy,refractory,patients,induce,term,durable,While,inflammatory,toxicities,related,expansion,can,life,threatening,iterative,recognition,treatment,cytokine,release,syndrome,CRS,sequelae,thereof,along,development,pre,emptive,interventions,supportive,care,measures,facilitated,implementation,across,populations,Additionally,tolerance,off,enabled,therapeutic,where,broad,was,substantial,concern
AB值:
0.650763
相似文献
Targeting the Rac1 pathway for improved prostate cancer therapy using polymeric nanoparticles to deliver of NSC23766
Zean Li;Jun Huang;Tao Du;Yiming Lai;Kaiwen Li;Man-Li Luo;Dingjun Zhu;Jun Wu;Hai Huang-Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510220,China;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Medical Research Center,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Obstetrics and Gynecology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Urology,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China
Nanoparticles targeting at methylases with high correlation to N6-methyladenosine-related lncRNA signatures as potential therapy of kidney clear cell carcinoma
Ruixuan Chen;Ping Ouyang;Licong Su;Xi Xu;Penghu Lian;Yanqin Li;Qi Gao;Yifan Zhang;Sheng Nie;Fan Luo;Ruqi Xu;Xiaodong Zhang;Xiaoxi Li;Yue Cao;Peiyan Gao;Juanjuan Kang;Jun Wu;Lu Li-National Clinical Research Center for Kidney Disease,State Key Laboratory of Organ Failure Research,Guangdong Provincial Clinical Research Center for Kidney Disease,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Health Management,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Hematology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Urology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College(CAMS&PUMC),Beijing 100730,China;Department of Urology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Affiliated Foshan Maternity&Child Healthcare Hospital,Southern Medical University,Foshan 528000,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Radiation Oncology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China
Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury
Ting-Ting Cao;Huan Chen;Mao Pang;Si-Si Xu;Hui-Quan Wen;Bin Liu;Li-Min Rong;Mang-Mang Li-Department of Cell Biology,School of Basic Medical Sciences,Southern Medical University,Guangzhou,Guangdong Province,China;Department of Spine Surgery,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong Province,China;Guangdong Provincial Center for Engineering and Technology Research of Minimally Invasive Spine Surgery,Guangzhou,Guangdong Province,China;Guangdong Provincial Center for Quality Control of Minimally Invasive Spine Surgery,Guangzhou,Guangdong Province,China;Department of Radiology,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong Province,China
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。